Mechanism of Secondary Brain Injury after Intracerebral Hemorrhage Based on DNA Demethylase TET1 and the Therapeutic Role of Vitamin C

When a blood vessel bursts inside the brain, the initial damage is often just the beginning. The bleeding itself causes immediate harm, but the real danger to a patient's long-term survival and recovery comes from what happens next. In the days following the event, the brain launches a chaotic internal response that can kill healthy cells far from the original injury site. This secondary wave of damage, driven by inflammation and oxidative stress, is currently the primary reason why so many people suffer severe disability or death after a brain hemorrhage. Doctors have few tools to stop this process. While they can manage the bleeding, they lack a way to switch off the cellular machinery that triggers the brain's own self-destruction. For years, scientists have looked for a way to intervene in this destructive cycle, hoping to find a lever that could calm the storm and save the tissue that is still alive.

Recent research has turned its attention to the chemical switches that control how genes are read within our cells. One such switch involves a process called DNA methylation, where tiny chemical tags are added to the genetic code to silence specific instructions. To keep the brain healthy, it needs to be able to remove these tags when necessary, a task performed by a family of proteins known as TET enzymes. Among them, a specific protein called TET1 is found in high concentrations in brain cells and is essential for keeping neurons alive and functioning. The researchers behind a new study from Zhengzhou University and its affiliated hospitals wanted to know what happens to this vital protein when a brain hemorrhage occurs, and whether a common, safe vitamin could help restore it.

The team began by creating a model of the injury in mice, injecting a substance that causes a controlled bleed in the brain's striatum, a region critical for movement and coordination. They then watched the timeline of the injury unfold over several days. As the blood clot formed and began to break down, the mice showed clear signs of distress: they struggled to balance, had trouble moving their limbs, and their brains swelled with fluid. At the same time, the researchers examined the brain tissue and found a startling drop in the levels of the TET1 protein. This loss was not random; it happened specifically in the neurons, the very cells that needed protection the most. The disappearance of TET1 coincided perfectly with the rise in cell death, suggesting that when the brain loses this protein, it loses its ability to stop the suicide program that kills neurons.

To test if this connection was the cause of the damage, the scientists tried to force the brain to make more TET1. They used a harmless virus to deliver extra copies of the TET1 gene directly into the brains of mice before the injury was induced. The result was dramatic. These mice, which had high levels of the protein, suffered far less brain swelling and recovered their movement much faster than the control group. Inside their cells, the researchers saw that the extra TET1 had changed the balance of proteins that control cell death. It boosted the levels of a protein that keeps cells alive while suppressing the ones that trigger self-destruction. This proved that TET1 acts as a guardian, and when it is present, the brain can resist the secondary injury that usually follows a hemorrhage.

The next question was whether this guardian could be summoned using a simple, existing treatment. The researchers turned to Vitamin C, a nutrient well known for its ability to fight oxidative stress. Crucially, Vitamin C is also a necessary helper, or cofactor, that allows TET enzymes to function. Without it, the TET proteins cannot do their job of removing the chemical tags from DNA. The team tested different doses of Vitamin C in the mice, ranging from 200 to 1,000 milligrams per kilogram of body weight. They found that a dose of 500 milligrams per kilogram was the sweet spot. This amount was enough to restore TET1 levels in the brain to near-normal, reactivating the enzyme's ability to clean the genetic switches. Mice treated with this specific dose showed significantly less brain swelling and far fewer dead neurons compared to those that received no treatment.

However, to be absolutely certain that Vitamin C was working through TET1 and not just by acting as a general antioxidant, the researchers performed a critical control experiment. They used a group of mice that had been genetically modified to have very low levels of TET1. When these mice were given the high dose of Vitamin C, the treatment failed completely. The Vitamin C could not save them because the specific protein it was meant to help was missing. The mice still suffered severe brain swelling and high rates of cell death, just like the untreated animals. This confirmed that the protective power of Vitamin C in this context is entirely dependent on its ability to boost TET1 activity. The vitamin does not work by a vague, general mechanism; it works by specifically turning on this one epigenetic switch.

The study concludes that the rapid loss of TET1 is a key driver of the secondary brain injury that follows a hemorrhage. By restoring this protein, either through genetic engineering or by providing the body with the right amount of Vitamin C, it is possible to halt the cascade of cell death and reduce brain swelling. The findings suggest that a high dose of Vitamin C, which is safe, inexpensive, and able to cross the blood-brain barrier, could be a powerful new tool for doctors. It offers a way to target the specific epigenetic machinery that fails during a stroke, potentially changing the outcome for patients who currently have no effective treatment options beyond managing the initial bleed. While the research was conducted in mice and focused on the acute phase of the injury, the mechanism identified provides a clear, actionable path forward for developing therapies that protect the brain when it is most vulnerable.